A tyrosine kinase inhibitor-induced interferon response positively associates with clinical response in EGFR-mutant lung cancer
酪氨酸激酶抑制剂诱导的干扰素反应与 EGFR 突变肺癌的临床反应呈正相关
期刊:npj Precision Oncology
影响因子:6.8
doi:10.1038/s41698-021-00181-4
Natalia J Gurule, Caroline E McCoach, Trista K Hinz, Daniel T Merrick, Adriaan Van Bokhoven, Jihye Kim, Tejas Patil, Jacob Calhoun, Raphael A Nemenoff, Aik Choon Tan, Robert C Doebele, Lynn E Heasley
